nandrolone has been researched along with Fracture, Pathologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaves, PH; Frisoli, A; Pinheiro, MM; Szejnfeld, VL | 1 |
| Holló, I; Horváth, C; Kollin, E; Szathmári, M; Szücs, J | 1 |
| Christiansen, C; Hassager, C; Pødenphant, J; Riis, BJ | 1 |
2 trial(s) available for nandrolone and Fracture, Pathologic
| Article | Year |
|---|---|
The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Androgens; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Nandrolone; Osteoporosis, Postmenopausal; Probability; Prospective Studies; Reference Values; Risk Assessment; Statistics, Nonparametric; Treatment Outcome | 2005 |
Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
Topics: Aged; Anabolic Agents; Body Mass Index; Bone Density; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Lipoproteins; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Time Factors | 1989 |
1 other study(ies) available for nandrolone and Fracture, Pathologic
| Article | Year |
|---|---|
[Treatment of postmenopausal osteoporosis with low doses of calcitonin and a calcitonin-anabolic combination].
Topics: Aged; Calcitonin; Drug Therapy, Combination; Female; Fractures, Spontaneous; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Osteoporosis, Postmenopausal; Spinal Fractures | 1992 |